Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Dorsey

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Ohio State Medical Journal|November 1, 1977
Mental disorders among physiciansE R Dorsey
Diseases of the Nervous System|October 1, 1977
The neuropharmacology of depressionA B Adolphe, E R Dorsey, M J Napoliello
Neurology|July 30, 2008
Quantitative risk-benefit analysis of natalizumabJ P Thompson, K Noyes, E R Dorsey, et al.
Neurology|August 31, 2011
Teaching NeuroImages: myelopathy due to B₁₂ deficiency in long-term colchicine treatment and nitrous oxide misuseJ C Probasco, R J Felling, J T Carson, et al.
Neurology|July 22, 2009
Selegiline shortage: Causes and costs of a generic drug shortageE R Dorsey, J P Thompson, E J Dayoub, et al.
Neurology|May 2, 2007
Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosisE R Dorsey, J P Thompson, K Noyes, et al.
Parkinsonism & Related Disorders|March 31, 2015
Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot studyS Arora, V Venkataraman, A Zhan, et al.
Journal of Huntington'S Disease|July 27, 2014
Plasma 8-hydroxy-2'-deoxyguanosine Levels in Huntington Disease and Healthy Controls Treated with Coenzyme Q10K M Biglan, E R Dorsey, R V V Evans, et al.
Clinical Genetics|November 22, 2012
Knowledge of the Genetic Information Nondiscrimination act among individuals affected by Huntington diseaseE R Dorsey, K C Darwin, P E Nichols, et al.
Neurology|April 29, 2011
Group patient visits for Parkinson disease: a randomized feasibility trialE R Dorsey, L M Deuel, C A Beck, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Ohio State Medical Journal|November 1, 1977
Mental disorders among physiciansE R Dorsey
Diseases of the Nervous System|October 1, 1977
The neuropharmacology of depressionA B Adolphe, E R Dorsey, M J Napoliello
Neurology|July 30, 2008
Quantitative risk-benefit analysis of natalizumabJ P Thompson, K Noyes, E R Dorsey, et al.
Neurology|August 31, 2011
Teaching NeuroImages: myelopathy due to B₁₂ deficiency in long-term colchicine treatment and nitrous oxide misuseJ C Probasco, R J Felling, J T Carson, et al.
Neurology|July 22, 2009
Selegiline shortage: Causes and costs of a generic drug shortageE R Dorsey, J P Thompson, E J Dayoub, et al.
Neurology|May 2, 2007
Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosisE R Dorsey, J P Thompson, K Noyes, et al.
Parkinsonism & Related Disorders|March 31, 2015
Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot studyS Arora, V Venkataraman, A Zhan, et al.
Journal of Huntington'S Disease|July 27, 2014
Plasma 8-hydroxy-2'-deoxyguanosine Levels in Huntington Disease and Healthy Controls Treated with Coenzyme Q10K M Biglan, E R Dorsey, R V V Evans, et al.
Clinical Genetics|November 22, 2012
Knowledge of the Genetic Information Nondiscrimination act among individuals affected by Huntington diseaseE R Dorsey, K C Darwin, P E Nichols, et al.
Neurology|April 29, 2011
Group patient visits for Parkinson disease: a randomized feasibility trialE R Dorsey, L M Deuel, C A Beck, et al.
Pageof 2